Chediak-Higashi Syndrome - An Overview

What Is Chediak-Higashi Syndrome?

Chediak-Higashi syndrome is a disorder that affects the immune system and several physiological systems. Immune system cells are harmed by this illness, making them less able to repel invaders like viruses and bacteria. Because of this, the majority of individuals with Chediak-Higashi syndrome experience recurrent and ongoing infections beginning in infancy or early childhood. These infections frequently pose a high risk of death.

Oculocutaneous albinism, which results in unusually pale coloration (pigmentation) of the skin, hair, and eyes, is another feature of Chediak-Higashi syndrome. Those affected frequently have light-colored hair with a metallic shine and pale complexion. Other visual issues brought on by oculocutaneous albinism include blurred vision, nystagmus, and increased sensitivity to light (photophobia). Numerous Chediak-Higashi syndrome sufferers have coagulation issues, which make it simple to bruise easily and experience unusual bleeding. Chediak-Higashi syndrome can also have an impact on the neurological system in adults, leading to weakness, clumsiness, trouble walking, and seizures.

What Are the Other Names for Chediak-Higashi Syndrome?

The other names of Chediak-Higashi syndrome are:

• CHS.

• Oculocutaneous albinism with leukocyte defect.

• Chediak-Steinbrinck-Higashi syndrome.

Who Is Affected by Chediak-Higashi Syndrome?

People of different ages, races, and ethnicities may be affected by the uncommon inherited immunodeficiency condition known as Chediak-Higashi syndrome (CHS):

• Gender: Both men and women are equally impacted.

• Age: The condition can be evident at birth or soon after, but it usually starts after delivery and before the age of five.

• Inheritance: CHS is an autosomal recessive disorder. Symptoms cannot manifest in a kid unless both parents have a non-functional copy of the gene.

What Are the Symptoms of Chediak-Higashi Syndrome?

Children who suffer from this illness may:

• Light-colored eyes and silver hair (albinism).

• increased rates of skin, mucous membranes, and lung infections.

• unexpected eye movements, or nystagmus.

• When afflicted children contract specific viruses, like Epstein-Barr virus (EBV), it can result in hemophagocytic lymphohistiocytosis, a potentially fatal condition that resembles blood malignancy lymphoma.

Additional signs and symptoms could be:

• Reduced vision.

• Impairment of intellect.

• Weakening of the muscles.

• Peripheral neuropathy, or difficulties with the nerves in the limbs.

• Bleeding or easily bruised.

• Absence of feeling.

• Shiver.

• Seizures.

• Light sensitivity (photophobia).

• Walking unsteadily (ataxia).

What Are the Causes of Chediak-Higashi Syndrome?

• LYST Gene: Mutations in the LYST gene are the cause of Chediak-Higashi syndrome. The lysosomal trafficking regulator protein is made using instructions from this gene. According to researchers, this protein is involved in the movement of materials into lysosomes and other related cell structures. Within cells, lysosomes serve as hubs for recycling. Invading bacteria are digested, harmful compounds are broken down, and worn-out cell parts are recycled using digestive enzymes. The size, shape, and function of lysosomes and associated structures in cells throughout the body are disrupted by mutations in the LYST gene, which affects the lysosomal trafficking regulator protein's ability to operate normally. Many cells have unusually big lysosomes that obstruct typical cell processes. For instance, certain immune system cells with larger lysosomes are unable to react to germs and other external invaders as they should. As a result, the body's immune system can not defend itself against infections.

• Melanosomes: Cellular components called melanosomes, which are linked to lysosomes, are considerable pigment cells called melanocytes. The material that gives skin, hair, and eyes their color is melanin, which is produced and distributed by melanosomes. Melanin is unable to contribute to the coloring of the skin, hair, or eyes in people with Chediak-Higashi syndrome because it is imprisoned within the enormous melanosomes. As a result, these people suffer oculocutaneous albinism.

• Platelets: The aberrant bruising and bleeding observed in patients with Chediak-Higashi syndrome are thought to be caused by lysosome-like structures that are abnormally shaped inside blood cells called platelets. The neurological issues linked to this illness are likely brought on by aberrant lysosomes in nerve cells.

How Is Chediak-Higashi Syndrome Diagnosed?

• Genetic testing.

• A complete blood count, including the number of white blood cells

• platelet count in blood.

• Smear and culture of blood.

• Magnetic resonance imaging (MRI).

• Computed tomography scan (CT scan) of the brain.

• Electrocardiogram (ECG).

• Electromyography (EMG).

• Tests for nerve conduction.

• Common conditions include neutropenia (reduced neutrophil counts in the blood compared to normal), hypergammaglobulinemia (when the body produces too many immunoglobulins), and reduced cytotoxicity of natural killer cells.

• Huge granules in neutrophils and other cells are inspected in a peripheral blood smear; huge inclusion bodies in leukocyte precursor cells are inspected in a bone marrow smear.

• Genetic testing for LYST mutations can confirm the diagnosis of Chédiak-Higashi syndrome.

• Relatives should not be screened unless there is a high level of clinical suspicion because this condition is extremely rare. It is very unlikely that a sibling who is a carrier may meet another carrier and become pregnant.

What Is the Treatment for Chediak-Higashi Syndrome?

• Supportive treatment with

  • Corticosteroids.

  • Interferon-gamma.

  • Antibiotics as needed.

• Transplanting hematopoietic stem cells.

• Certain youngsters whose illness is in the stable phase may benefit from high dosages of vitamin C.

• During the rapid stage of the illness, antiviral medications such as acyclovir and chemotherapeutic therapies are frequently administered.

• Transfusions of blood and platelets are administered as needed.

• In certain instances, surgery may be required to drain abscesses.

Interferon-gamma can aid in the restoration of some immune system functions, while prophylactic antibiotics can aid in the prevention of infections. Splenectomy and corticosteroid pulse dosages can occasionally provide a brief remission of Chédiak-Higashi syndrome.

However, most Chédiak-Higashi syndrome patients pass away from infections by the time they are 7 years old if hematopoietic stem cell transplantation is not performed. Following pretransplantation cytoreductive chemotherapy, unfractionated bone marrow matching the donor's HLA may be transplanted. The survival rate five years after transplantation is almost 60 percent.

What Is the Prognosis of Chediak-Higashi Syndrome?

Death from long-term (chronic) infections or accelerated disease that causes hemophagocytic lympho histiocytosis, a condition that resembles lymphoma, frequently happens in the first ten years of life. Some impacted kids have, nevertheless, lived longer.

Conclusion:

The immune system is most impacted by Chediak-Higashi syndrome, although other physiological systems are also affected. This illness damages immune system cells, leaving them less able to defend against foreign invaders like viruses and bacteria. As a result, the majority of people with Chediak-Higashi syndrome begin to endure chronic and recurring infections in infancy or early childhood. The danger of mortality from these illnesses is usually very high.